SCHEDULE: Harris Associates Amends Envista Holdings Stake
Beneficial Ownership Report
Harris Associates L.P. and Harris Associates, Inc. have filed an amended Schedule 13G, reporting a 4.6% beneficial ownership in Envista Holdings Corp.
Summary
- Harris Associates L.P. and Harris Associates, Inc. filed an Amendment No. 2 to Schedule 13G regarding their beneficial ownership in Envista Holdings Corp.
- The filing pertains to Common Stock, $0.01 par value, of Envista Holdings Corp. (CUSIP: 29415F104).
- As of June 30, 2025, the aggregate amount beneficially owned by the reporting persons is 7,812,256 shares.
- This ownership represents 4.6% of the class of securities.
- Harris Associates L.P. and Harris Associates, Inc. hold sole voting power over 6,182,724 shares and sole dispositive power over 7,812,256 shares.
- The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
Sentiment
Score: 5
Explanation: Neutral, as this is a routine disclosure of beneficial ownership by an institutional investor, not a performance report or a significant change in control.
Positives
- A significant institutional investor, Harris Associates, maintains a substantial stake in Envista Holdings Corp.
- The filing indicates a passive investment strategy, as the shares are held in the ordinary course of business and not for control purposes, suggesting a long-term investment horizon.
Negatives
- The filing itself does not contain specific negative financial or operational information about Envista Holdings Corp.
Risks
- The Schedule 13G filing itself does not detail specific operational or financial risks of Envista Holdings Corp.
Future Outlook
This Schedule 13G filing is a disclosure of current beneficial ownership and does not provide forward-looking statements or guidance regarding Envista Holdings Corp.'s future performance or strategic outlook.
Management Comments
- The securities referred to were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities.
Industry Context
This filing is a routine disclosure of an institutional investor's stake and does not provide specific insights into broader industry trends or competitive dynamics within the dental or healthcare sectors.
Stakeholder Impact
- Shareholders: Provides transparency on significant institutional holdings, which can influence market perception and investor confidence.
Key Dates
| Date | Description |
|---|---|
| 06/30/2025 | Date of event which requires filing of this statement. |
| 08/14/2025 | Date of signing of the Schedule 13G Amendment No. 2 by Joseph J. Allessie, General Counsel and Secretary for Harris Associates L.P. and Harris Associates, Inc. |
Keywords
Envista Holdings, Harris Associates, Schedule 13G, SEC filing, beneficial ownership, institutional investor, common stock, dental, healthcare
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.